Maryland, 3 Jan 2025: FDA published a draft guidance document on Jan. 2, 2025 that provides considerations for complying with 21 Code of Federal Regulations (CFR) 211.110 (1). This specific section of the CFR focuses on production and process c......
View Details

Related News

• Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics (16-01-2025)

---

• Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)

---

• FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)

---

• Dabur sues Patanjali over toothpaste trade dress (16-01-2025)

---

• Wrappers of drug brands found from Paonta printing press premises (16-01-2025)

---

• PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)

---

• Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)

---

• Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)

---

• SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)

---

• 3600 Proxyvon capsule consignment going to Nepal caught (15-01-2025)

---